Skip to content
Innovision IPO

Innovision IPO GMP Today: Grey Market Premium & Key Details

Innovision IPO GMP (Grey Market Premium)

The Innovision IPO has attracted attention from investors as it opens for subscription between 10 March 2026 and 12 March 2026. This mainboard IPO aims to raise around ₹323 crore through a combination of fresh issue shares and an offer for sale.

 Innovision IPO

Innovision IPO GMP Trend

Date IPO GMP GMP Trend Gain
12 March ₹71 12.96%
11 March ₹60 10.95%
10 March ₹- -%
9 March ₹- -%

Innovision IPO

Before the official stock market listing, many investors track the Grey Market Premium (GMP). The GMP represents the price at which IPO shares are traded unofficially in the grey market before listing. It helps give an idea of market sentiment and possible listing expectations, although it is not an official or guaranteed indicator.

Innovision IPO Details

IPO Open Date March 10, 2026
IPO Close Date March 12, 2026
Face Value ₹10 Per Equity Share
IPO Price Band ₹521 to ₹548 Per Share
Issue Size Approx ₹323 Crores
Fresh Issue Approx ₹255 Crores
Offer for Sale: Approx 12,38,000 Equity Shares
Issue Type Book build Issue
IPO Listing BSE, NSE

For the Innovision IPO, grey market activity has been limited so far, and the GMP trend has remained flat, suggesting that investors are waiting for stronger subscription demand and overall market signals. As the IPO progresses and more investors participate, the GMP may change based on demand and sentiment.

Innovision IPO

Innovision IPO Dates

IPO Open Date: March 10, 2026
IPO Close Date: March 12, 2026
Basis of Allotment: March 13, 2026
Refunds: March 16, 2026
Credit to Demat Account: March 16, 2026
IPO Listing Date: March 17, 2026

The IPO price band for Innovision has been fixed between ₹521 and ₹548 per share, and the company plans to list its shares on BSE and NSE after the allotment process is completed.

Investors often watch GMP trends along with other factors like subscription numbers, company fundamentals, and overall market conditions before deciding whether to apply for an IPO. While GMP can provide a rough indication of expected listing performance, it should not be the only factor considered when making investment decisions.

Back To Top